Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Affimed N.V. | 11 | 6 | 0 | 0 | €0.55 | €7.92 | 1331.338% |
| Teleflex Inc. | 11 | 0 | 2 | 0 | €218.00 | €245.97 | 12.829% |
| Amedisys Inc. | 11 | 0 | 0 | 0 | €87.00 | €92.26 | 6.046% |
| Idexx Laboratories Inc. | 12 | 0 | 0 | 0 | €435.30 | €554.23 | 27.321% |
| LivaNova plc | 12 | 0 | 1 | 0 | €42.00 | €66.49 | 58.314% |
| Gilead Sciences Inc | 12 | 1 | 1 | 0 | €71.46 | €84.81 | 18.685% |
| QIAGEN NV | 12 | 0 | 1 | 0 | €40.47 | €47.52 | 17.415% |
| AnaptysBio Inc | 12 | 1 | 3 | 0 | €33.00 | €48.09 | 45.719% |
| Staar Surgical Co. | 13 | 1 | 1 | 0 | €29.30 | €47.59 | 62.435% |
| Prothena Corp. plc | 13 | 0 | 2 | 0 | €19.10 | €78.70 | 312.045% |
| Incyte Corp. | 13 | 2 | 1 | 0 | €59.42 | €77.67 | 30.716% |
| Charles River Labs Intl | 13 | 0 | 2 | 0 | €178.90 | €247.61 | 38.406% |
| Rigel Pharmaceutical Inc. | 13 | 0 | 0 | 0 | €0.74 | €13.86 | 1772.365% |
| Twist Bioscience Corp | 13 | 1 | 2 | 1 | €39.08 | €41.80 | 6.962% |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 2 | 0 | €18.32 | €26.64 | 45.451% |
| Verastem Inc. | 14 | 0 | 3 | 0 | €2.26 | €16.16 | 615.102% |
| MacroGenics Inc. | 14 | 0 | 2 | 0 | €3.18 | €12.31 | 286.950% |
| Universal Health Services B | 14 | 6 | 1 | 0 | €216.00 | €150.90 | -30.138% |
| Stoke Therapeutics Inc | 14 | 1 | 1 | 0 | €12.50 | €20.33 | 62.668% |
| Rhythm Pharmaceuticals | 15 | 0 | 1 | 0 | €44.80 | €46.51 | 3.806% |
| Henry Schein Inc. | 15 | 1 | 3 | 0 | €63.84 | €76.08 | 19.172% |
| Intellia Therapeutics Inc | 15 | 1 | 2 | 0 | €20.31 | €60.53 | 198.021% |
| Laboratory Corp. Of America (labcorp) | 15 | 0 | 4 | 0 | €197.00 | €239.41 | 21.527% |
| PTC Therapeutics Inc. | 15 | 9 | 3 | 0 | €31.60 | €41.51 | 31.369% |
| Ocular Therapeutix Inc. | 15 | 4 | 1 | 0 | €7.98 | €13.09 | 63.988% |